Drug Shortage Report for RAN-METFORMIN
Report ID | 97781 |
Drug Identification Number | 02269058 |
Brand name | RAN-METFORMIN |
Common or Proper name | RAN-METFORMIN |
Company Name | RANBAXY PHARMACEUTICALS CANADA INC. |
Market Status | DORMANT |
Active Ingredient(s) | METFORMIN HYDROCHLORIDE |
Strength(s) | 850MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | 100 |
ATC code | A10BA |
ATC description | BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2019-10-25 |
Estimated end date | 2019-11-15 |
Actual end date | 2019-11-15 |
Shortage status | Resolved |
Updated date | 2019-11-26 |
Company comments | Discontinued |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 126 EAST DRIVE BRAMPTON, ONTARIO CANADA L6T 1C1 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2019-11-01 | English | Compare |
v2 | 2019-11-01 | French | Compare |
v3 | 2019-11-26 | English | Compare |
v4 | 2019-11-26 | French | Compare |
Showing 1 to 4 of 4